Assyro AI

Orange Book product · Brand (NDA)

EPSOLAY

BENZOYL PEROXIDE

Brand (NDA)NDA 214510RX MAYNE PHARMA

At a glance

Apr 22, 2022

Approved

Brand (NDA)

Application

Not listed

TE code

14

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 22, 2022

    4 yr 3 mo ago

  2. Today

  3. Patent 12156946 expires

    Listed drug product patent expiration.

    Feb 03, 2028

    in 1 yr 8 mo

  4. Patent 12350382 expires

    Listed drug product patent expiration.

    Feb 03, 2028

    in 1 yr 8 mo

  5. Patent 9868103 expires

    Listed drug product patent expiration.

    Aug 08, 2028

    in 2 yr 2 mo

  6. Patent 9687465 expires

    Listed drug product patent expiration.

    Nov 27, 2032

    in 6 yr 6 mo

  7. Patent 10933046 expires

    Listed drug product patent expiration.

    Feb 19, 2040

    in 13 yr 10 mo

  8. Patent 10945987 expires

    Listed method-of-use patent (U-3356) expiration.

    Feb 19, 2040

    in 13 yr 10 mo

  9. Patent 11541026 expires

    Listed method-of-use patent (U-3356) expiration.

    Feb 19, 2040

    in 13 yr 10 mo

  10. Patent 11865100 expires

    Listed method-of-use patent (U-3357) expiration.

    Feb 19, 2040

    in 13 yr 10 mo

  11. Patent 11877997 expires

    Listed method-of-use patent (U-3356) expiration.

    Feb 19, 2040

    in 13 yr 10 mo

  12. Patent 11986456 expires

    Listed method-of-use patent (U-3947) expiration.

    Feb 19, 2040

    in 13 yr 10 mo

  13. Patent 11426378 expires

    Listed method-of-use patent (U-3356) expiration.

    Aug 18, 2040

    in 14 yr 4 mo

  14. Patent 11628155 expires

    Listed method-of-use patent (U-3356) expiration.

    Dec 27, 2040

    in 14 yr 9 mo

  15. Patent 12295935 expires

    Listed method-of-use patent (U-3356) expiration.

    Dec 27, 2040

    in 14 yr 9 mo

  16. Patent 12257348 expires

    Listed drug product patent expiration.

    May 23, 2041

    in 15 yr 2 mo

Pharmaceutical detail

Active ingredient

BENZOYL PEROXIDE

Strength

5%

Dosage form

CREAM

Route

TOPICAL

TE code

Not listed

Application

NDA 214510

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (14)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12156946Feb 03, 2028in 1 yr 8 mo
Product
12350382Feb 03, 2028in 1 yr 8 mo
Product
9868103Aug 08, 2028in 2 yr 2 mo
ProductU-3356
9687465Nov 27, 2032in 6 yr 6 mo
ProductU-3356
10933046Feb 19, 2040in 13 yr 10 mo
ProductU-3357
10945987Feb 19, 2040in 13 yr 10 mo
U-3356
11541026Feb 19, 2040in 13 yr 10 mo
U-3356
11865100Feb 19, 2040in 13 yr 10 mo
U-3357
11877997Feb 19, 2040in 13 yr 10 mo
U-3356
11986456Feb 19, 2040in 13 yr 10 mo
U-3947
11426378Aug 18, 2040in 14 yr 4 mo
U-3356
11628155Dec 27, 2040in 14 yr 9 mo
U-3356
12295935Dec 27, 2040in 14 yr 9 mo
U-3356
12257348May 23, 2041in 15 yr 2 mo
ProductU-3947
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.